NASDAQ:RMTI Rockwell Medical (RMTI) Stock Price, News & Analysis $5.54 0.00 (0.00%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$5.44 -0.11 (-1.90%) As of 07/2/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock About Rockwell Medical Stock (NASDAQ:RMTI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Rockwell Medical alerts:Sign Up Key Stats Today's Range$4.89▼$5.5650-Day Range$5.19▼$9.0052-Week Range$4.89▼$21.00Volume90,570 shsAverage Volume40,625 shsMarket Capitalization$21.87 millionP/E RatioN/ADividend YieldN/APrice Target$20.00Consensus RatingHold Company Overview Rockwell Medical, Inc. is a Delaware‐domiciled biopharmaceutical company focused on the development and commercialization of therapies for patients with chronic kidney disease (CKD). The company’s mission centers on addressing common complications in CKD—namely iron deficiency and secondary hyperparathyroidism—through innovative treatment approaches designed for dialysis settings. The company’s lead product, TRIFERIC®, is an iron replacement therapy approved by the U.S. Food and Drug Administration for use in hemodialysis patients. TRIFERIC is delivered via dialysate and is intended to replace iron losses that occur during the dialysis process, helping to maintain hemoglobin levels without the need for intravenous iron supplements. In addition to TRIFERIC, Rockwell Medical offers a generic injectable formulation of calcitriol, a form of vitamin D used to manage secondary hyperparathyroidism in CKD patients. Since its founding in 1991, Rockwell Medical has conducted research, clinical development, and regulatory activities primarily in the United States. The company collaborates with specialty distributors and dialysis providers to commercialize its products and is exploring further innovations, including oral formulations of its iron therapy. Rockwell Medical’s operations are led by an experienced management team with backgrounds in nephrology, pharmaceutical development, and health-care commercialization, reflecting its commitment to improving patient outcomes in the CKD community.AI Generated. May Contain Errors. Read More Rockwell Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks51st Percentile Overall ScoreRMTI MarketRank™: Rockwell Medical scored higher than 51% of companies evaluated by MarketBeat, and ranked 419th out of 852 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingRockwell Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.Upside PotentialRockwell Medical has a consensus price target of $20.00, representing about 261.0% upside from its current price of $5.54.Amount of Analyst CoverageRockwell Medical has only been the subject of 2 research reports in the past 90 days.Read more about Rockwell Medical's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Rockwell Medical are expected to grow in the coming year, from ($0.80) to $0.50 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Rockwell Medical is -3.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Rockwell Medical is -3.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRockwell Medical has a P/B Ratio of 0.59. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Rockwell Medical's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.95% of the float of Rockwell Medical has been sold short.Short Interest Ratio / Days to CoverRockwell Medical has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Rockwell Medical has recently increased by 91.22%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldRockwell Medical does not currently pay a dividend.Dividend GrowthRockwell Medical does not have a long track record of dividend growth. News and Social Media1.1 / 5News Sentiment-0.20 News SentimentRockwell Medical has a news sentiment score of -0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Rockwell Medical this week, compared to 2 articles on an average week.Search InterestOnly 2 people have searched for RMTI on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership0.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Rockwell Medical insiders have not sold or bought any company stock.Percentage Held by Insiders4.60% of the stock of Rockwell Medical is held by insiders.Percentage Held by Institutions23.31% of the stock of Rockwell Medical is held by institutions.Read more about Rockwell Medical's insider trading history. Receive RMTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rockwell Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RMTI Stock News HeadlinesRockwell Medical announces first reverse stock split in 4 years – Nasdaq compliance in focus as shares haven’t traded above $1 since MarchJune 29, 2026 | msn.comRockwell Med Announces One-for-Ten Reverse Stock SplitJune 29, 2026 | tipranks.comStranded On The Flood Plains of HistoryThe petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War. Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving. Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar.July 4 at 1:00 AM | Porter & Company (Ad)Rockwell Medical Announces 1-for-10 Reverse Stock SplitJune 29, 2026 | businesswire.comRockwell Medical (NASDAQ:RMTI) vs. Verano (OTCMKTS:VRNOF) Critical SurveyJune 27, 2026 | americanbankingnews.comRMTI Share News TodayJune 23, 2026 | uk.investing.comRockwell Medical Shareholders Approve Board, Pay and Reverse SplitJune 15, 2026 | tipranks.comRockwell Medical: Buy Rating Reiterated as Analyst Maintains $2 Price Target on Strengthening Commercial OutlookMay 22, 2026 | tipranks.comSee More Headlines RMTI Stock Analysis - Frequently Asked Questions How have RMTI shares performed this year? Rockwell Medical's stock was trading at $8.3350 at the beginning of the year. Since then, RMTI stock has decreased by 33.5% and is now trading at $5.54. How were Rockwell Medical's earnings last quarter? Rockwell Medical, Inc. (NASDAQ:RMTI) announced its earnings results on Thursday, May, 7th. The company reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by $0.30. The business had revenue of $17.34 million for the quarter, compared to the consensus estimate of $17.95 million. Rockwell Medical had a negative net margin of 7.98% and a negative trailing twelve-month return on equity of 15.41%. Read the conference call transcript. When did Rockwell Medical's stock split? Rockwell Medical shares reverse split on Wednesday, July 1st 2026.The 1-10 reverse split was announced on Monday, June 29th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, June 30th 2026. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of Rockwell Medical? Shares of RMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Rockwell Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Rockwell Medical investors own include NVIDIA (NVDA), Super Micro Computer (SMCI), Axcelis Technologies (ACLS), Opera (OPRA), ADMA Biologics (ADMA), ASML (ASML) and InterDigital (IDCC). Company Calendar Last Earnings5/07/2026Today7/04/2026Next Earnings (Estimated)8/13/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 RMTI's financial health is in the Red zone, according to TradeSmith. RMTI has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:RMTI CIK1041024 Webwww.rockwellmed.com Phone(248) 432-1362Fax248-960-9119Employees300Year Founded1995Price Target and Rating Average Price Target for Rockwell Medical$20.00 High Price Target$20.00 Low Price Target$20.00 Potential Upside/Downside+261.0%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($1.50) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$5.31 million Net Margins-7.98% Pretax Margin-7.98% Return on Equity-15.41% Return on Assets-9.62% Debt Debt-to-Equity Ratio0.23 Current Ratio3.74 Quick Ratio3.43 Sales & Book Value Annual Sales$67.68 million Price / Sales0.32 Cash FlowN/A Price / Cash FlowN/A Book Value$9.38 per share Price / Book0.59Miscellaneous Outstanding Shares3,947,000Free Float3,765,000Market Cap$21.87 million OptionableOptionable Beta1.61 Social Links 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (NASDAQ:RMTI) was last updated on 7/4/2026 by MarketBeat.com Staff. From Our PartnersWorld’s Largest Investors Are Moving Their Money (Not Into AI)While headlines focus on the next AI IPO, the world's largest investors are moving capital into one asset at t...Stansberry Research | SponsoredGoldman Sachs: 300 million jobs will disappearGoldman Sachs predicts 300 million jobs will disappear - and Elon Musk's 'Project Apex' AI supercomputer is ac...InvestorPlace | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredHe turned $12,415 into millions. Now he wants to help you.Tim Sykes turned $12,415 in bar mitzvah money into over $7 million in trading profits - and more than 50 of hi...Tim Sykes | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rockwell Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rockwell Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
